QT Vascular gets US nod on four key patents
Singapore
MEDICAL supplies group QT Vascular said the United States Patent and Trademark Office has issued allowance letters of four fundamental patents that are key to its portfolio of specialty balloons for the treatment of vascular disease in coronary and peripheral vessels.
The Catalist-listed firm on Wednesday said three of the patents cover the group's flagship platform, Chocolate®, while the fourth covers its Glider™ family of products.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Japan’s Sumitomo Corp net profit down 32% on Madagascar one-off loss
DBS customers unable to log into Digibank, PayLah! on Thursday
Moody's tops quarterly profit estimates on strong product demand
Hong Kong regulator brings insider trading charges against Segantii and its founder
Novartis to buy radiology specialist Mariana Oncology for US$1 billion
Moderna beats quarterly estimates as cost-cutting pares losses